Renin system activation and delayed function of the renal transplant

Jon D. Blumenfeld, Daniel F. Catanzaro, Milan Kinkhabwala, Jhoong Cheigh, Choli Hartono, David Serur, Sandi Kapur, William T. Stubenbord, Rudy Haschemeyer, Robert Riggio

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Delayed graft function (DGF), defined as persistent renal failure that requires dialysis within the first week after kidney transplantation, occurs commonly after cadaveric renal transplantation (CRT). This has important implications for long-term outcome because the 1-year allograft survival rate is significantly reduced when DGF occurs. The mechanisms contributing to the development of DGF are not well established. However, several lines of evidence indicate that excess renin system activity, in both the cadaver kidney donor and recipient, contributes importantly to the pathogenesis of DGF. If this hypothesis can be verified in clinical studies, then pharmacologic agents that interrupt the renin-angiotensin system (eg, type 1 angiotensin II receptor blockade, angiotensin converting enzyme inhibition, and β-adrenergic blockade) in the donor and recipient might significantly improve the outcome of cadaveric renal transplants.

Original languageEnglish (US)
Pages (from-to)1270-1272
Number of pages3
JournalAmerican Journal of Hypertension
Volume14
Issue number12
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Delayed Graft Function
Renin
Transplants
Kidney
Kidney Transplantation
Angiotensin Type 1 Receptor
Peptidyl-Dipeptidase A
Renin-Angiotensin System
Cadaver
Adrenergic Agents
Renal Insufficiency
Allografts
Dialysis

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Blumenfeld, J. D., Catanzaro, D. F., Kinkhabwala, M., Cheigh, J., Hartono, C., Serur, D., ... Riggio, R. (2001). Renin system activation and delayed function of the renal transplant. American Journal of Hypertension, 14(12), 1270-1272. https://doi.org/10.1016/S0895-7061(01)02264-6

Renin system activation and delayed function of the renal transplant. / Blumenfeld, Jon D.; Catanzaro, Daniel F.; Kinkhabwala, Milan; Cheigh, Jhoong; Hartono, Choli; Serur, David; Kapur, Sandi; Stubenbord, William T.; Haschemeyer, Rudy; Riggio, Robert.

In: American Journal of Hypertension, Vol. 14, No. 12, 2001, p. 1270-1272.

Research output: Contribution to journalArticle

Blumenfeld, JD, Catanzaro, DF, Kinkhabwala, M, Cheigh, J, Hartono, C, Serur, D, Kapur, S, Stubenbord, WT, Haschemeyer, R & Riggio, R 2001, 'Renin system activation and delayed function of the renal transplant', American Journal of Hypertension, vol. 14, no. 12, pp. 1270-1272. https://doi.org/10.1016/S0895-7061(01)02264-6
Blumenfeld, Jon D. ; Catanzaro, Daniel F. ; Kinkhabwala, Milan ; Cheigh, Jhoong ; Hartono, Choli ; Serur, David ; Kapur, Sandi ; Stubenbord, William T. ; Haschemeyer, Rudy ; Riggio, Robert. / Renin system activation and delayed function of the renal transplant. In: American Journal of Hypertension. 2001 ; Vol. 14, No. 12. pp. 1270-1272.
@article{0024089d63794cbfa5abfc42269f870e,
title = "Renin system activation and delayed function of the renal transplant",
abstract = "Delayed graft function (DGF), defined as persistent renal failure that requires dialysis within the first week after kidney transplantation, occurs commonly after cadaveric renal transplantation (CRT). This has important implications for long-term outcome because the 1-year allograft survival rate is significantly reduced when DGF occurs. The mechanisms contributing to the development of DGF are not well established. However, several lines of evidence indicate that excess renin system activity, in both the cadaver kidney donor and recipient, contributes importantly to the pathogenesis of DGF. If this hypothesis can be verified in clinical studies, then pharmacologic agents that interrupt the renin-angiotensin system (eg, type 1 angiotensin II receptor blockade, angiotensin converting enzyme inhibition, and β-adrenergic blockade) in the donor and recipient might significantly improve the outcome of cadaveric renal transplants.",
author = "Blumenfeld, {Jon D.} and Catanzaro, {Daniel F.} and Milan Kinkhabwala and Jhoong Cheigh and Choli Hartono and David Serur and Sandi Kapur and Stubenbord, {William T.} and Rudy Haschemeyer and Robert Riggio",
year = "2001",
doi = "10.1016/S0895-7061(01)02264-6",
language = "English (US)",
volume = "14",
pages = "1270--1272",
journal = "Journal of Clinical Hypertension",
issn = "0895-7061",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - Renin system activation and delayed function of the renal transplant

AU - Blumenfeld, Jon D.

AU - Catanzaro, Daniel F.

AU - Kinkhabwala, Milan

AU - Cheigh, Jhoong

AU - Hartono, Choli

AU - Serur, David

AU - Kapur, Sandi

AU - Stubenbord, William T.

AU - Haschemeyer, Rudy

AU - Riggio, Robert

PY - 2001

Y1 - 2001

N2 - Delayed graft function (DGF), defined as persistent renal failure that requires dialysis within the first week after kidney transplantation, occurs commonly after cadaveric renal transplantation (CRT). This has important implications for long-term outcome because the 1-year allograft survival rate is significantly reduced when DGF occurs. The mechanisms contributing to the development of DGF are not well established. However, several lines of evidence indicate that excess renin system activity, in both the cadaver kidney donor and recipient, contributes importantly to the pathogenesis of DGF. If this hypothesis can be verified in clinical studies, then pharmacologic agents that interrupt the renin-angiotensin system (eg, type 1 angiotensin II receptor blockade, angiotensin converting enzyme inhibition, and β-adrenergic blockade) in the donor and recipient might significantly improve the outcome of cadaveric renal transplants.

AB - Delayed graft function (DGF), defined as persistent renal failure that requires dialysis within the first week after kidney transplantation, occurs commonly after cadaveric renal transplantation (CRT). This has important implications for long-term outcome because the 1-year allograft survival rate is significantly reduced when DGF occurs. The mechanisms contributing to the development of DGF are not well established. However, several lines of evidence indicate that excess renin system activity, in both the cadaver kidney donor and recipient, contributes importantly to the pathogenesis of DGF. If this hypothesis can be verified in clinical studies, then pharmacologic agents that interrupt the renin-angiotensin system (eg, type 1 angiotensin II receptor blockade, angiotensin converting enzyme inhibition, and β-adrenergic blockade) in the donor and recipient might significantly improve the outcome of cadaveric renal transplants.

UR - http://www.scopus.com/inward/record.url?scp=0035217685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035217685&partnerID=8YFLogxK

U2 - 10.1016/S0895-7061(01)02264-6

DO - 10.1016/S0895-7061(01)02264-6

M3 - Article

VL - 14

SP - 1270

EP - 1272

JO - Journal of Clinical Hypertension

JF - Journal of Clinical Hypertension

SN - 0895-7061

IS - 12

ER -